Vident Advisory’s Elevance Health ELV Stock Holding History

Vident Advisory's ELV Position: Q2 2026 in Review

Vident Advisory increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $5.49M and bringing the position to 132,285 shares worth $51.2M. The position accounts for 0.37% of the portfolio, ranked #55.

Vident Advisory first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

• Vident Advisory held 132,285 shares of Elevance Health worth $51.2M as of Q2 2026.
• Vident Advisory bought 14,812 Elevance Health shares in Q2 2026, an estimated $5.49M.
• Elevance Health made up 0.37% of Vident Advisory's portfolio in Q2 2026, its #55 holding.
• Vident Advisory first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
• 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.